What 9 Analyst Ratings Have To Say About Taysha Gene Therapies benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Jing-Qiong (Katty) Kang, M.D., Ph.D., associate professor of Neurology and Pharmacology, Vanderbilt University Medical Center. view more
Credit: Vanderbilt University Medical Center
Researchers at Vanderbilt University Medical Center (VUMC) have identified a common mechanism underlying a spectrum of epilepsy syndromes and neurodevelopmental disorders, including autism, that are caused by variations in a gene encoding a vital transporter protein in the brain.
Their findings, reported last month in the journal
Brain, suggest that boosting transporter function via genetic or pharmacological means could be beneficial in treating brain disorders linked to these genetic variations. This points (to) a clear direction of treating a wide spectrum of neurodevelopmental disorders, from various epilepsy syndromes (and) autism to neurodevelopmental delay and intellectual disabilities, caused by the pathological variants in this gene, said Jing-Qiong (Katty) Kan
Bearish
8 analysts offering 12-month price targets in the last 3 months for Taysha Gene Therapies evaluate the company at an average price target of $45.19 with a high of $67.50 and a low of $30.00.
This current average has increased by 10.22% from the previous average price target of $41.0.
What Are Analyst Ratings?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish analyst ratings for stocks. Analysts typically rate each stock once per quarter.
Analysts may suggest actions like buy , sell , hold , or similar verbage for each stock based on research compiled from the corresponding company. Analysts who suggest buy are telling traders to purchase the stock based on forecasted growth. On the flip side, analysts who suggest sell are telling traders to dump the stock bec
Abeona Therapeutics Issues Letter to Stockholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.